Droia Oncology Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 27
  • Portfolio
  • 14
  • Exits
  • 6
Exits

Droia Oncology Ventures General Information

Description

Founded in 2011, Droia Oncology Ventures is a venture capital firm based in Meise, Belgium. The firm has an additional office in Luxembourg, Luxembourg. The firm focuses on the development of oncology therapies and early-stage drug development companies.

Contact Information

Year Founded
2011
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Brusselsesteenweg 11
  • 1860 Meise
  • Belgium
+32 02 000 00 00

Droia Oncology Ventures Investments (27)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ambagon Therapeutics 05-Jan-2022 Early Stage VC 0000 Drug Discovery Startup
0000 000000000000 09-Jul-2021 00000 00000 000.00 Drug Discovery Generating Revenue 000 000000
00000000 000000000 25-Jun-2021 00000 00000 000.00 Drug Discovery Pre-Clinical Trials
00000000000 000000 18-May-2021 00000 00000 00000 Drug Discovery Clinical Trials - General
00000000 06-Apr-2021 00000 00000 0000 Drug Discovery Startup 000 000000
000000 00000000000 01-Mar-2021 0000 00000 000.00 Drug Discovery Startup 000 000000
000000 00000000000 11-Feb-2021 00000 00000 0000 Drug Discovery Pre-Clinical Trials 000000000 0000000
0000000 0000000000 29-Jul-2020 0000 00000 0000 Drug Discovery Startup
QurAlis 13-May-2020 Early Stage VC 0000 Drug Discovery Generating Revenue 000 000000
Accent Therapeutics 23-Apr-2020 Early Stage VC 0000 Biotechnology Generating Revenue
You’re viewing 10 of 27 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Droia Oncology Ventures Exits (6)

Company Name Exit Date Exit Type Exit Size
Aura Biosciences 29-Oct-2021 IPO 000.00
000000 00000000000 18-Jun-2021 000 00000
0000 000000000000 27-Sep-2018 000000000000000000 00000
00000000 01-Sep-2018 000 00 00000000
Arcus Biosciences 15-Mar-2018 IPO 00000
PX Biosolutions 01-Aug-2016 Out of Business
To view Droia Oncology Ventures’s complete exits history, request access »

Droia Oncology Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Droia Oncology Ventures Team (16)

Name Title Deals Funds Boards Office
Lionel de Hemptinne Chief Financial Officer Meise, Belgium
Joke Vereecken Principal Meise, Belgium
Matthias Van Woensel Ph.D Principal Meise, Belgium
Luc Verelst Co-Founder & Chairman 0 0 0 Meise, Belgium
Roderick Beijersbergen Investment Advisory Board Member Meise, Belgium
You’re viewing 5 of 16 team members. Get the full list »

Droia Oncology Ventures Co-Investors (91)

Name With Exits Lead Partner Series Industry
Polaris Partners 5 0 Series chart Industry bar
AbbVie Ventures 0 0 Series chart Industry bar
Novo Holdings 0 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
Amgen Ventures 0 0 Series chart Industry bar
You’re viewing 5 of 91 co-investors. Get the full list »